Tempus AI, Inc.
TEM
อันดับในหุ้น
#1886
Tempus AI, Inc. operates as a healthcare technology company in the United... Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
ราคาหุ้น
$64.29
ซิงค์ล่าสุด: 2026-10-16
มูลค่าตลาด
$11.28B
การเปลี่ยนแปลง (1 วัน)
-9.62%
การเปลี่ยนแปลง (1 ปี)
-26.76%
ประเทศ
US
ซื้อขาย Tempus AI, Inc. (TEM)
หมวดหมู่
Healthcare
EPS สำหรับ Tempus AI, Inc. (TEM)
EPS ณ วันที่ June 2026 TTM: $-1.43
จากรายงานทางการเงินล่าสุดและราคาหุ้นของ Tempus AI, Inc. EPS ปัจจุบันของบริษัท (TTM) คือ $-1.43 สิ้นปี 2023 บริษัทมี EPS เท่ากับ $-1.73 น้อยกว่ารายได้ในปี EPS ในปี 2022 ซึ่งอยู่ที่ $-1.97
ประวัติ EPS ของ Tempus AI, Inc. ตั้งแต่ 2019 ถึง 2026
EPS ณ สิ้นแต่ละปี
| ปี | EPS | เปลี่ยน |
|---|---|---|
| 2026 (TTM) | $-1.43 | -68.91% |
| 2024 | $-4.60 | 166.85% |
| 2023 | $-1.73 | -12.24% |
| 2022 | $-1.97 | 12.15% |
| 2021 | $-1.75 | 17.27% |
| 2020 | $-1.49 | 62.46% |
| 2019 | $-0.92 | 0.00% |
EPS สำหรับบริษัทหรือคู่แข่งที่คล้ายกัน
| บริษัท | EPS | ความแตกต่างของ EPS | ประเทศ |
|---|---|---|---|
| $3.48 | -343.36% |
US
|
|
| $1.79 | -225.27% |
AU
|
|
| $1.43 | -200.00% |
US
|
|
| $-0.59 | -58.74% |
US
|
|
| - | - |
US
|
